Avg closing price
Price range

25 Cathie Wood CRISPR Therapeutics AG Trades

Cathie Wood's position in CRISPR Therapeutics AG is currently worth $719 Million. That's 4.33% of their equity portfolio (6th largest holding). The investor owns 10.39% of the outstanding CRISPR Therapeutics AG stock. The first CRISPR Therapeutics AG trade was made in Q2 2017. Since then Cathie Wood bought shares seventeen more times and sold shares on nine occasions. The stake costed the investor $606 Million, netting the investor a gain of 19% so far.

Avg closing price
Price range
Increased shares by 19.2% (+1.37 Million shares) Q4 2023
Avg closing price $55.28
Price range $38.62 - $72.18
Sold 2.4% shares (-175 Thousand shares) Q3 2023
Avg closing price $51.65
Price range $45.39 - $59.00
Sold 8.2% shares (-652 Thousand shares) Q2 2023
Avg closing price $56.74
Price range $43.47 - $67.77
Increased shares by 2.0% (+160 Thousand shares) Q1 2023
Avg closing price $48.57
Price range $41.00 - $56.12
Sold 4.9% shares (-407 Thousand shares) Q4 2022
Avg closing price $53.05
Price range $39.19 - $65.67
Sold 15.3% shares (-1.49 Million shares) Q3 2022
Avg closing price $72.47
Price range $61.10 - $83.78
Increased shares by 3.4% (+323 Thousand shares) Q2 2022
Avg closing price $58.79
Price range $43.23 - $73.83
Increased shares by 3.5% (+316 Thousand shares) Q1 2022
Avg closing price $62.79
Price range $53.19 - $79.24
Increased shares by 19.8% (+1.5 Million shares) Q4 2021
Avg closing price $87.36
Price range $70.09 - $111.29
Sold 2.4% shares (-190 Thousand shares) Q3 2021
Avg closing price $125.59
Price range $110.20 - $156.64
Sold 6.2% shares (-514 Thousand shares) Q2 2021
Avg closing price $121.62
Price range $100.84 - $161.89
Sold 20.4% shares (-2.12 Million shares) Q1 2021
Avg closing price $151.00
Price range $110.72 - $210.04
Increased shares by 23.1% (+1.96 Million shares) Q4 2020
Avg closing price $118.20
Price range $79.67 - $173.23
Increased shares by 30.4% (+1.97 Million shares) Q3 2020
Avg closing price $88.70
Price range $78.50 - $100.64
Increased shares by 51.3% (+2.2 Million shares) Q2 2020
Avg closing price $58.47
Price range $38.50 - $76.05
Increased shares by 44.9% (+1.33 Million shares) Q1 2020
Avg closing price $51.63
Price range $33.68 - $62.53
Increased shares by 46.1% (+934 Thousand shares) Q4 2019
Avg closing price $54.60
Price range $36.68 - $73.13
Increased shares by 52.7% (+698 Thousand shares) Q1 2019
Avg closing price $34.57
Price range $28.02 - $40.87
Sold 8.8% shares (-128 Thousand shares) Q4 2018
Avg closing price $34.76
Price range $22.73 - $42.34
Increased shares by 211.2% (+986 Thousand shares) Q3 2018
Avg closing price $52.37
Price range $44.35 - $65.71

News about CRISPR Therapeutics AG and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!